Breast Cancer, Version 3.2022

The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. These NCCN Clinical Practice Guidelines for Breast Cancer include recommendations for clinical management of patients with carcinoma in situ, invasive breast cancer, Paget disease, phyllodes tumor, inflammatory breast cancer, and management of breast cancer during pregnancy. The content featured in this issue focuses on the recommendations for overall management of ductal carcinoma in situ and the workup and locoregional management of early stage invasive breast cancer. For the full version of the NCCN Guidelines for Breast Cancer, visit NCCN.org. J Natl Compr Canc Netw 2022;20(6):691-722 doi: 10.6004/jnccn.2022.0030

Automated summary

This article discusses the complex therapeutic options for patients with noninvasive or invasive breast cancer, as well as the recommendations provided by the NCCN Clinical Practice Guidelines for Breast Cancer. It focuses on the overall management of ductal carcinoma in situ and the workup and locoregional management of early stage invasive breast cancer.